[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620317":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":29,"responsibleParty":77,"collaborators":79,"id":85,"slug":10,"hasResults":86,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":90,"eligibilityCriteria":91,"healthyVolunteers":86,"sex":92,"minAge":93,"maxAge":94,"enrollmentInfo":95,"targetDuration":10,"studyType":98,"phases":10,"briefSummary":99,"conditions":100,"keywords":104,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":115},{"fullName":5,"class":6},"Children's Hospital Medical Center, Cincinnati","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Second Measles Vaccine (MV2)",null,"Participants who receive second measles vaccine.",{"label":13,"type":10,"description":14,"interventionNames":10},"First Measles Vaccine (MV1)","Participants who obtain the first measles vaccine.",[16],{"name":17,"affiliation":5,"role":18},"Alexandra Power-Hays, MD","PRINCIPAL_INVESTIGATOR",[20,25],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Teresa Latham","CONTACT","513-803-7922","Teresa.Latham@cchmc.org",{"name":26,"role":22,"phone":27,"phoneExt":10,"email":28},"Amy Shova","(513) 803-1917","Amy.Shova@cchmc.org",[30,50,63],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Cincinnati Children's Hospital Medical Center","RECRUITING","Cincinnati","Ohio","45229","United States",{"type":38,"coordinates":39},"Point",[40,41],-84.51439,39.12711,{"lat":41,"lon":40},[44,48],{"name":45,"role":22,"phone":46,"phoneExt":10,"email":47},"MacKenzie Tasset","513-803-4856","MacKenzie.Tasset@cchmc.org",{"name":49,"role":18,"phone":10,"phoneExt":10,"email":10},"Charles Quinn, MD",{"facility":51,"status":32,"city":52,"state":53,"zip":10,"country":53,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"Korle Bu Teaching Hospital","Accra","Ghana",{"type":38,"coordinates":55},[56,57],-0.1969,5.55602,{"lat":57,"lon":56},[60,61],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},{"name":62,"role":18,"phone":10,"phoneExt":10,"email":10},"Catherine Segbefia, MBChB, FWACP, GGCPS",{"facility":64,"status":32,"city":65,"state":10,"zip":10,"country":66,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"Bugando Medical Centre","Mwanza","Tanzania",{"type":38,"coordinates":68},[69,70],32.9,-2.51667,{"lat":70,"lon":69},[73,75],{"name":74,"role":22,"phone":23,"phoneExt":10,"email":24},"Teresa Latham, PhD",{"name":76,"role":18,"phone":10,"phoneExt":10,"email":10},"Emmanuela Ambrose, MD, MMED",{"type":78,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[80,82],{"name":81,"class":6},"Thrasher Research Fund",{"name":83,"class":84},"National Institutes of Health (NIH)","NIH","100620317",false,"NCT07356050","Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease","Verifying Antibodies After Live Immunization Delivery (VALID): a Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease","VALID","Inclusion Criteria:\n\n1. Participants with confirmed Sickle Cell Disease.\n2. Participants 6 months and 6 years of age and due for measles vaccination within 3 months per national guidelines.\n3. Willing and able to provide informed consent\n4. Ability to comply with study related evaluations and follow-up visits.\n\nExclusion Criteria:\n\n1\\. Known primary immunodeficiency syndrome, cancer, or acquired immunodeficiency syndrome (AIDS) that would preclude vaccination with live virus vaccines.","ALL","6 Months","6 Years",{"count":96,"type":97},130,"ESTIMATED","OBSERVATIONAL","The goal of this study is to learn if infants with sickle cell disease (SCD) develop adequate protection after measles vaccines. (not looking at any prolonged duration)",[101,102,103],"Sickle Cell Disease","Measles Vaccination","Sickle Cell Anemia",[105],"Measles Vaccine Immunogenicity","2026-01-20",{"date":108,"type":109},"2026-01-21","ACTUAL",{"date":111,"type":109},"2025-03-13",{"date":113,"type":97},"2028-12-31",{"name":5,"class":6},3]